Korean J Anesthesiol.  2012 Dec;63(6):559-562. 10.4097/kjae.2012.63.6.559.

Cardiac arrest with pulmonary edema in a non-parturient after ergonovine administration recovered with extracorporeal membrane oxygenation: A case report

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea. yklee@catholic.ac.kr

Abstract

Ergonovine have been used for the prevention and treatment of postpartum or postabortion hemorrhage. Although this modality has been considered relatively safe in the obstetric patients, there were a few cardiac events associated with this drug in the post-delivery or post-abortion patients, especially in patients with cardiovascular risk factors. We experienced cardiac arrest in a non-parturient with no discernible risk factors. Although resuscitated, she also suffered from pulmonary edema with unstable hemodynamics and low oxygenation. To manage the patient, extracorporeal membrane oxygenation was used and she recovered successfully without cardiopulmonary complications. Therefore, we recommend that when ergonovine is chosen as a modality, special caution should be paid to the pulmonary events, as well as cardiac, especially when administered by intravenously even in patients with no cardiovascular risk factors. If cardiac events occur, extracorporeal membrane oxygenation or other measures, such as intra-aortic balloon pump can be helpful when conventional cardiopulmonary resuscitation is not effective.

Keyword

Cardiac arrest; Ergonovine; Extracorporeal membrane oxygenation; Pulmonary edema

MeSH Terms

Aftercare
Cardiopulmonary Resuscitation
Ergonovine
Extracorporeal Membrane Oxygenation
Heart Arrest
Hemodynamics
Hemorrhage
Humans
Membranes
Oxygen
Postpartum Period
Pulmonary Edema
Risk Factors
Ergonovine
Oxygen
Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr